10 Best Short Squeeze Stocks to Buy According to Analysts
This article will look into the 10 best short-squeeze stocks that have gained analysts' attention. Stock market trading has an ever-changing environment.
Arrivent Biopharma Inc. (AVBP)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 4,515,531 | $156,869,547 | +3% | 2.87% |
| 2. | Hillhouse Capital Management Lei Zhang | 3,929,117 | $136,497,525 | 16.4% | |
| 3. | OrbiMed Advisors Samuel Isaly | 3,027,328 | $105,169,375 | 1.95% | |
| 4. | Octagon Capital Advisors Ting Jia | 1,971,054 | $68,474,416 | 6.15% | |
| 5. | Vivo Capital Albert Cha And Frank Kung | 1,682,097 | $58,436,050 | +90% | 5.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 555,555 | $9,999,990.00 | 4,484,672 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.37 | 555,555 | $12,983,320.35 | 3,929,117 | 2025-12-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,438,384 | $154,189,460 | 15.68% | |
| 2. | 3,250,396 | $112,918,757 | 0% | |
| 3. | 2,778,959 | $96,541,033 | 0% | |
| 4. | 1,774,873 | $61,659,088 | 0% | |
| 5. | 1,696,752 | $58,945,164 | 3.05% |
News See All
